|
|
|||||||||||||||
Tuberculosis is the most common cause of death in adults. Many tuberculosis patients in South Asia, the worst affected region of the world, receive very poor treatment from private doctors. A public-private partnership has been set up in Nepal to improve the treatment of the disease. In urban parts of Nepal 50 percent of tuberculosis (TB) patients see a private doctor. Poor quality of care can lead to relapse, more people becoming infected and drug-resistant strains of the disease developing. As part of their DOTS strategy, The World Health Organisation (WHO) encourages the direct observation of treatment (DOT) to ensure patients complete their course of treatment. DOT means a health worker observes patients swallowing each dose of their medicine. The UK's Nuffield Institute for Health helped to set up a public-private partnership (PPP) in the Nepalese city of Lalitpur in order to improve the quality of TB care. The city’s district health officer took on the responsibility for running the programme. The aim of the partnership is to combine the strengths of all partners in providing TB care. It involves developing a referral mechanism from private doctors to DOT centres, training health workers, maintaining the drug supply and making sure that the DOT centres follow standard procedures. Private doctors in the PPP receive maps of the city showing the location of treatment centres and guidelines for referral. Volunteers chase up patients who do not attend the clinics on time for treatment and a chest physician treats complicated TB cases. The PPP was successful. A survey of TB patients was carried out in 1998 before the PPP was introduced and another survey was conducted three years later. Comparisons of survey results showed that:
The study suggests that similar arrangements should be made elsewhere in Asia. Setting up a PPP should not be difficult because:
A PPP can provide a service that patients like to use, give high success rates and increase the numbers of patients receiving treatment. However, a PPP for control of TB should only be set up where the country’s national TB programme is strong. If the national TB programme is weak the private sector with its low cure rates is likely to expand in an uncontrolled way. Such a development could lead to widespread drug-resistant TB and would be disastrous for low-income countries. Source(s): Funded by: UK Department for International Development id21 Research Highlight: 19 October 2005
Further Information: Contact the contributor: j.n.newell@leeds.ac.uk Nuffield Centre for International Health and Development, University of Leeds, UK Other related links:
|
|
||||||||||||||
|
|
|
|
|
|
|||||||||||